People who have asthma or bronchitis or other lung conditions often take prescribed medications through an inhaler—a device that releases the medication in a spray so that it reaches its target—the ...

In a cohort of adults with chronic obstructive pulmonary disease (COPD), receiving fluticasone-umeclidinium-vilanterol was ...

Half advice show. Half survival guide. Half absurdity-fest. (Wait, how does this work again? We're not numbers people.) Each episode, we answer all your burning questions, from how to survive a ...

European regulators have refused to back GlaxoSmithKline’s daily triple therapy Trelegy Ellipta for asthma ... thanks to its ageing asthma and COPD inhaler Advair, which finally succumbed ...

A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm ...

The medication segment was the largest in 2022, favored for its cost-effectiveness and common use as a first-line treatment. .Centriacinar Emphysema Growth: The centriacinar segment, primarily linked ...

In 1961, the Company started manufacturing Vitamin A and Betamethasone at new plant at Thane using imported ... It launched Trelegy Ellipta, the countrys first single inhaler triple therapy ...